BioXcel Therapeutics, Inc. (BTAI) Social Stream
BIOXCEL THERAPEUTICS INC (BTAI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BTAI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 6 | $140 | $75 | $101.375 | $18.15 | 458.54% |
| 2021-12-16 | 7 | $140 | $75 | $101.375 | $18.15 | 458.54% |
| 2022-01-13 | 7 | $140 | $73 | $99.75 | $18.15 | 449.59% |
| 2022-02-01 | 7 | $140 | $73 | $99.428 | $18.15 | 447.81% |
| 2022-03-10 | 6 | $140 | $73 | $99.428 | $18.15 | 447.81% |
| 2022-03-18 | 6 | $130 | $73 | $98.5 | $18.15 | 442.7% |
| 2022-04-06 | 5 | $130 | $73 | $98.5 | $18.15 | 442.7% |
| 2022-04-08 | 5 | $130 | $75 | $97.714 | $18.15 | 438.37% |
| 2022-04-14 | 4 | $134 | $76 | $102.166 | $18.15 | 462.9% |
| 2022-04-25 | 4 | $134 | $76 | $101.833 | $18.15 | 461.06% |
| 2022-05-09 | 4 | $134 | $62 | $90.5 | $18.15 | 398.62% |
| 2022-05-10 | 4 | $134 | $20 | $76.833 | $18.15 | 323.32% |
| 2022-05-13 | 4 | $134 | $20 | $76.571 | $18.15 | 321.88% |
| 2022-05-23 | 4 | $110 | $20 | $73.142 | $18.15 | 302.99% |
| 2022-06-08 | 4 | $110 | $20 | $71.714 | $18.15 | 295.12% |
| 2022-07-07 | 5 | $110 | $19 | $62.428 | $18.15 | 243.96% |
| 2022-08-13 | 5 | $110 | $19 | $61.571 | $18.15 | 239.23% |
| 2022-09-17 | 5 | $90 | $19 | $58 | $18.15 | 219.56% |
| 2022-11-16 | 7 | $85 | $18 | $52.625 | $18.15 | 189.94% |
| 2022-12-01 | 8 | $85 | $16 | $48.555 | $18.15 | 167.52% |
| 2022-12-15 | 8 | $85 | $16 | $49.222 | $18.15 | 171.2% |
| 2023-01-03 | 8 | $82 | $16 | $47.888 | $18.15 | 163.85% |
| 2023-01-26 | 8 | $82 | $20 | $49 | $18.15 | 169.97% |
| 2023-01-30 | 8 | $78 | $20 | $48.555 | $18.15 | 167.52% |
| 2023-02-08 | 8 | $78 | $20 | $48.777 | $18.15 | 168.74% |
| 2023-02-21 | 8 | $79 | $20 | $51 | $18.15 | 180.99% |
| 2023-03-09 | 8 | $79 | $20 | $51 | $18.15 | 180.99% |
| 2023-03-10 | 8 | $79 | $22 | $51.222 | $18.15 | 182.21% |
| 2023-03-21 | 8 | $78 | $22 | $49.666 | $18.15 | 173.64% |
| 2023-03-31 | 8 | $75 | $22 | $49.333 | $18.15 | 171.81% |
| 2023-05-08 | 8 | $75 | $22 | $49 | $18.15 | 169.97% |
| 2023-05-10 | 8 | $75 | $22 | $51.444 | $18.15 | 183.44% |
| 2023-05-11 | 8 | $75 | $24 | $51.666 | $18.15 | 184.66% |
| 2023-05-30 | 8 | $75 | $24 | $51.555 | $18.15 | 184.05% |
The Trend in the Analyst Price Target
Over the past 26 months, BTAI's average price target has gone down $53.63.
BTAI reports an average of 177.17% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-09 | 5 | 110 | 19 | 61.571 | 15.36 | 300.85% |
| 2023-02-08 | 8 | 78 | 20 | 50.333 | 33.24 | 51.42% |
| 2023-02-21 | 8 | 79 | 20 | 51.000 | 31.86 | 60.08% |
| 2023-03-22 | 8 | 75 | 22 | 49.333 | 17.83 | 176.69% |
| 2023-05-11 | 8 | 75 | 24 | 51.666 | 27.07 | 90.86% |
BTAI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 6 | 0 | 2 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
BTAI's average broker recommendation rating worsened by 0.5 over the prior 52 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BTAI as an investment opportunity.
- In terms of how BIOXCEL THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 3414.28% of that group.
- In the context of all US stocks, BIOXCEL THERAPEUTICS INC's variance in analysts' estimates is lower than -3203.58% of them.
- In the context of stocks in the small market cap category, BIOXCEL THERAPEUTICS INC's average analyst price target is greater than 3677.47% of them.
- BTAI has a greater number of analysts covering the stock than 2813.84% of stocks in the small market cap category.
In the Pharmaceutical Products industry, MBIO, ACET, and KZIA are the three stocks most similar to BIOXCEL THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BTAI? Use POWR Ratings for clearer insight into price direction.